NCT01806363View on ClinicalTrials.gov

Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Hypertension
Interventions
DRUG

Telmisartan 80mg

DRUG

Chlorthalidone 25mg

Trial Locations (1)

700-721

Kyungpook national university hospital Clionical center, Daegu

Sponsors
All Listed Sponsors
lead

HanAll BioPharma Co., Ltd.

INDUSTRY

NCT01806363 - Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone | Biotech Hunter | Biotech Hunter